ClinicalTrials.gg
Sign In

Newish Biotech (Wuxi) Co., Ltd. clinical trials

The registry lists 14 studies whose lead sponsor is Newish Biotech (Wuxi) Co., Ltd. or one of 1 company grouped under it. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 17, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Get an email when these change. Save the Newish Biotech (Wuxi) Co., Ltd. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Pipeline: 3 programmes

Each counted once: 3 with a study Newish Biotech (Wuxi) Co., Ltd. leads registered in the last two years.

  • Phase 2

The 3 programmes — sign in to see the list, free: with every programme, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Newish Biotech (Wuxi) Co., Ltd.’s own registered studies; Newish Biotech (Wuxi) Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programmes are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Newish Biotech (Wuxi) Co., Ltd.’s studies test, most open studies first — 2 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

5 of Newish Biotech (Wuxi) Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. 1J
  9. J
  10. A
  11. 1S
  12. O
  13. N

All 5

Add all 5 to your calendar (.ics) → With an account.

All 14 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1393%Recruiting 11 · Not yet recruiting 2
  • Completed17%

Phase

  • Phase 16
  • Phase 25

Where

  • China13
  • United States1

Over the years

  1. 18
  2. 19
  3. 20
  4. 21
  5. 22
  6. 23
  7. 24
  8. 25
  9. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Newish Biotech (Wuxi) Co., Ltd..

  • Newish Technology (Beijing) Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Newish Biotech (Wuxi) Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies

Studies

Recruiting first, then most recently updated. Showing 14 of 14.